Drugcard
DrugCard revolutionizes pharmacovigilance, offering AI-driven solutions for local literature screening. Designed for Contract Research Organizations (CROs), Marketing Authorization Holders (MAHs), and freelancers, it simplifies the complex task of monitoring drug safety across multiple regions and languages.
Make a decision about Drugcard
- Already use it? Add Drugcard to Stack Autopsy — check cost, overlap and safe cancellations.
- Thinking about buying it? Ask AI Advisor — compare fit, alternatives and trade-offs.
- Want to leave it? Find a replacement — see feature losses and migration risks.
Pricing
- Free Tier: Experience DrugCard with a trial period customized upon request.
Features
- AI-Enabled Data Intelligence: Utilizes advanced AI algorithms to streamline pharmacovigilance processes, ensuring comprehensive drug safety monitoring.
- Multi-Language Support: Capable of screening medical literature in over 100 languages, making it a versatile tool for global use.
- OCR Technology: Proprietary OCR technology delivers up to 99% accuracy, even with poorly scanned texts, ensuring reliable data extraction.
- Scalable and Flexible: Easily adapts to new markets and integrates additional journals within 2-3 weeks, supporting multi-region operations.
Use cases
- Contract Research Organizations (CROs): Enhancing pharmacovigilance projects with efficient literature screening.
- Marketing Authorization Holders (MAHs): Streamlining in-house and outsourced literature screening processes.
- Pharmacovigilance Freelancers: Saving time and resources for more value-adding activities such as consulting and research.
- Pharmaceutical Companies: Ensuring regulatory compliance across multiple regions and languages.
- Uncommon Use Cases: Adopted by regulatory bodies for audit preparations; utilized by academic researchers for pharmacovigilance studies.